Ruikang Pharmaceutical Overview
- Year Founded
-
2004
- Status
-
Public
- Employees
-
2,407
- Stock Symbol
-
002589
- Investments
-
11
- Share Price
-
$0.43
- (As of Thursday Closing)
Ruikang Pharmaceutical General Information
Description
Realcan Pharmaceutical Group Co Ltd is a Chinese company engaged in direct pharmaceuticals distribution services. The company's main business is divided into the Drug, vaccine, medical device circulation service; Medical industry third-party logistics; Medical information service; Medical logistics service; Chinese medicine plate; Hospital management sector; Medical industry research and development production sector; and Medical industry financial sector.
Contact Information
Website
www.realcan.cnCorporate Office
- Building 13, No. 103, Fengming Road
- Zhifu District
- Yantai, Shandong 264004
- China
Corporate Office
- Building 13, No. 103, Fengming Road
- Zhifu District
- Yantai, Shandong 264004
- China
Ruikang Pharmaceutical Stock Performance
As of 12-Nov-2026, Ruikang Pharmaceutical’s stock price is $0.43. Its current market cap is $641M with 1.5B shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.43 | $0.43 | $0.35 - $0.66 | $641M | 1.5B | 101M |
Ruikang Pharmaceutical Financials Summary
As of 30-Sep-2026, Ruikang Pharmaceutical has a trailing 12-month revenue of $1.02B.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 669,593 | 924,273 | 959,442 | 481,277 |
| Revenue | 1,020,044 | 1,014,537 | 1,110,247 | 1,135,619 |
| EBITDA | 19,298 | 39,278 | 46,811 | 27,881 |
| Net Income | 1,915 | 2,235 | 1,713 | 2,872 |
| Total Assets | 2,300,456 | 2,053,803 | 2,196,922 | 2,357,208 |
| Total Debt | 758,061 | 658,157 | 901,908 | 962,714 |
Ruikang Pharmaceutical Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Ruikang Pharmaceutical Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Ruikang Pharmaceutical Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Ruikang Pharmaceutical Investments & Acquisitions (11)
Ruikang Pharmaceutical’s most recent deal was a Early Stage VC with Green Leaf Diagnosis. The deal was made on 21-Sep-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Green Leaf Diagnosis | 21-Sep-2026 | Early Stage VC | Diagnostic Equipment | ||
| Jilin Kuanghua Pharmaceutical Logistics | 16-Oct-2025 | Secondary Transaction - Private | Distributors/Wholesale | ||
| Guohui Health | 18-Feb-2022 | Corporate | Business/Productivity Software | ||
| Longhuikang | 10-Jul-2020 | Merger/Acquisition | Personal Products | ||
| MEIQI Medical | 20-May-2020 | Secondary Transaction - Private | Medical Supplies |
Ruikang Pharmaceutical ESG
Risk Overview
Risk Rating
Updated April, 30, 2024
23.82 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 15,201
Rank
Percentile
Healthcare
Industry
of 592
Rank
Percentile
Medical Distribution
Subindustry
of 49
Rank
Percentile
Ruikang Pharmaceutical Exits (3)
Ruikang Pharmaceutical’s most recent exit was on 18-Feb-2022 from Guohui Health. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Guohui Health | 18-Feb-2022 | Completed |
|
||
| Cezhan Pharmaceutical | 02-Jan-2018 | Completed |
|
||
| Shanghai Pharmaceuticals Holding (Hunan) | 25-Nov-2015 | Secondary Transaction - Private | Completed |
Ruikang Pharmaceutical Affiliates
Subsidiaries (3)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Longhuikang | Bozhou, China | 2020 | |
| Mongolian Medicine International | Tongliao, China | 2018 | |
| Hengjian Hospital Management | Weihai, China | 2017 |
Ruikang Pharmaceutical FAQs
-
When was Ruikang Pharmaceutical founded?
Ruikang Pharmaceutical was founded in 2004.
-
Where is Ruikang Pharmaceutical headquartered?
Ruikang Pharmaceutical is headquartered in Yantai, China.
-
What is the size of Ruikang Pharmaceutical?
Ruikang Pharmaceutical has 2,407 total employees.
-
What industry is Ruikang Pharmaceutical in?
Ruikang Pharmaceutical’s primary industry is Biotechnology.
-
Is Ruikang Pharmaceutical a private or public company?
Ruikang Pharmaceutical is a Public company.
-
What is Ruikang Pharmaceutical’s stock symbol?
The ticker symbol for Ruikang Pharmaceutical is 002589.
-
What is the current stock price of Ruikang Pharmaceutical?
As of 12-Nov-2026 the stock price of Ruikang Pharmaceutical is $0.43.
-
What is the current market cap of Ruikang Pharmaceutical?
The current market capitalization of Ruikang Pharmaceutical is $641M.
-
What is Ruikang Pharmaceutical’s current revenue?
The trailing twelve month revenue for Ruikang Pharmaceutical is $1.02B.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
